# Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes

> **NCT01707134** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 753 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin aspart
- **DRUG:** human soluble insulin
- **DRUG:** insulin NPH

## Key facts

- **NCT ID:** NCT01707134
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-09
- **Primary completion:** 2000-05
- **Final completion:** 2000-05
- **Target enrollment:** 753 (ACTUAL)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01707134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01707134, "Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01707134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*